TY - JOUR AU - Katsarou, A. AU - Gudbjörnsdottir, S. AU - Rawshani, A. AU - Dabelea, D. AU - Bonifacio, E. AU - Anderson, B. J. PY - 2017 DA - 2017// TI - Type 1 diabetes mellitus JO - Nat Rev Dis Primer VL - 3 UR - https://doi.org/10.1038/nrdp.2017.16 DO - 10.1038/nrdp.2017.16 ID - Katsarou2017 ER - TY - JOUR AU - Larsson, S. C. AU - Wallin, A. AU - Håkansson, N. AU - Stackelberg, O. AU - Bäck, M. AU - Wolk, A. PY - 2018 DA - 2018// TI - Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases JO - Int J Cardiol VL - 262 UR - https://doi.org/10.1016/j.ijcard.2018.03.099 DO - 10.1016/j.ijcard.2018.03.099 ID - Larsson2018 ER - TY - JOUR AU - Schofield, J. AU - Ho, J. AU - Soran, H. PY - 2019 DA - 2019// TI - Cardiovascular risk in type 1 diabetes mellitus JO - Diabetes Ther VL - 10 UR - https://doi.org/10.1007/s13300-019-0612-8 DO - 10.1007/s13300-019-0612-8 ID - Schofield2019 ER - TY - JOUR AU - Schmidt, A. M. AU - Stern, D. PY - 2000 DA - 2000// TI - Atherosclerosis and diabetes: the RAGE connection JO - Curr Atheroscler Rep VL - 2 UR - https://doi.org/10.1007/s11883-000-0082-4 DO - 10.1007/s11883-000-0082-4 ID - Schmidt2000 ER - TY - JOUR AU - Lind, M. AU - Svensson, A. -. M. AU - Kosiborod, M. AU - Gudbjörnsdottir, S. AU - Pivodic, A. AU - Wedel, H. PY - 2014 DA - 2014// TI - Glycemic control and excess mortality in type 1 diabetes JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1408214 DO - 10.1056/NEJMoa1408214 ID - Lind2014 ER - TY - JOUR AU - Ramasamy, R. AU - Yan, S. F. AU - D’Agati, V. AU - Schmidt, A. M. PY - 2007 DA - 2007// TI - Receptor for advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging JO - Curr Mol Med VL - 7 UR - https://doi.org/10.2174/156652407783220732 DO - 10.2174/156652407783220732 ID - Ramasamy2007 ER - TY - JOUR AU - Soro-Paavonen, A. AU - Watson, A. M. AU - Li, J. AU - Paavonen, K. AU - Koitka, A. AU - Calkin, A. C. PY - 2008 DA - 2008// TI - Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes JO - Diabetes. VL - 57 UR - https://doi.org/10.2337/db07-1808 DO - 10.2337/db07-1808 ID - Soro-Paavonen2008 ER - TY - JOUR AU - Yan, S. F. AU - Ramasamy, R. AU - Schmidt, A. M. PY - 2009 DA - 2009// TI - The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease JO - Expert Rev Mol Med VL - 11 UR - https://doi.org/10.1017/S146239940900101X DO - 10.1017/S146239940900101X ID - Yan2009 ER - TY - JOUR AU - Liberale, L. AU - Carbone, F. AU - Montecucco, F. AU - Sahebkar, A. PY - 2020 DA - 2020// TI - Statins reduce vascular inflammation in atherogenesis: a review of underlying molecular mechanisms JO - Int J Biochem Cell Biol VL - 122 UR - https://doi.org/10.1016/j.biocel.2020.105735 DO - 10.1016/j.biocel.2020.105735 ID - Liberale2020 ER - TY - JOUR AU - Kosaki, A. AU - Hasegawa, T. AU - Kimura, T. AU - Iida, K. AU - Hitomi, J. AU - Matsubara, H. PY - 2004 DA - 2004// TI - Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes JO - J Clin Endocrinol Metab VL - 89 UR - https://doi.org/10.1210/jc.2003-032223 DO - 10.1210/jc.2003-032223 ID - Kosaki2004 ER - TY - JOUR AU - Bucciarelli, L. AU - Wendt, T. AU - Rong, L. AU - Lalla, E. AU - Hofmann, M. AU - Goova, M. PY - 2002 DA - 2002// TI - RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease JO - Cell Mol Life Sci CMLS VL - 59 UR - https://doi.org/10.1007/s00018-002-8491-x DO - 10.1007/s00018-002-8491-x ID - Bucciarelli2002 ER - TY - JOUR AU - Lanati, N. AU - Emanuele, E. AU - Brondino, N. AU - Geroldi, D. PY - 2010 DA - 2010// TI - Soluble RAGE-modulating drugs: state-of-the-art and future perspectives for targeting vascular inflammation JO - Curr Vasc Pharmacol VL - 8 UR - https://doi.org/10.2174/157016110790226642 DO - 10.2174/157016110790226642 ID - Lanati2010 ER - TY - JOUR AU - Xu, L. AU - Wang, Y. -. R. AU - Li, P. -. C. AU - Feng, B. PY - 2016 DA - 2016// TI - Advanced glycation end products increase lipids accumulation in macrophages through upregulation of receptor of advanced glycation end products: increasing uptake, esterification and decreasing efflux of cholesterol JO - Lipids Health Dis VL - 15 UR - https://doi.org/10.1186/s12944-016-0334-0 DO - 10.1186/s12944-016-0334-0 ID - Xu2016 ER - TY - JOUR AU - Santilli, F. AU - Bucciarelli, L. AU - Noto, D. AU - Cefalù, A. B. AU - Davì, V. AU - Ferrante, E. PY - 2007 DA - 2007// TI - Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins JO - Free Radic Biol Med VL - 43 UR - https://doi.org/10.1016/j.freeradbiomed.2007.06.017 DO - 10.1016/j.freeradbiomed.2007.06.017 ID - Santilli2007 ER - TY - JOUR AU - Bucciarelli, L. G. AU - Wendt, T. AU - Qu, W. AU - Lu, Y. AU - Lalla, E. AU - Rong, L. L. PY - 2002 DA - 2002// TI - RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E–null mice JO - Circulation. VL - 106 UR - https://doi.org/10.1161/01.CIR.0000039325.03698.36 DO - 10.1161/01.CIR.0000039325.03698.36 ID - Bucciarelli2002 ER - TY - JOUR AU - Grauen Larsen, H. AU - Marinkovic, G. AU - Nilsson, P. M. AU - Nilsson, J. AU - Engström, G. AU - Melander, O. PY - 2019 DA - 2019// TI - High plasma sRAGE (soluble receptor for advanced glycation end products) is associated with slower carotid intima-media thickness progression and lower risk for first-time coronary events and mortality JO - Arterioscler Thromb Vasc Biol VL - 39 UR - https://doi.org/10.1161/ATVBAHA.118.312319 DO - 10.1161/ATVBAHA.118.312319 ID - Grauen Larsen2019 ER - TY - STD TI - Geroldi D, Falcone C, Emanuele E, D’Angelo A, Calcagnino M, Geroldi D, Falcone C, Emanuele E, D’Angelo A, Calcagnino M, Buzzi MP, et al. Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. J Hypertens. 2005:1725–9. ID - ref17 ER - TY - JOUR AU - Škrha, J. AU - Kalousová, M. AU - Švarcová, J. AU - Muravska, A. AU - Kvasnička, J. AU - Landova, L. PY - 2012 DA - 2012// TI - Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus JO - Exp Clin Endocrinol Diabetes VL - 120 UR - https://doi.org/10.1055/s-0031-1283161 DO - 10.1055/s-0031-1283161 ID - Škrha2012 ER - TY - JOUR AU - Cuccurullo, C. AU - Iezzi, A. AU - Fazia, M. L. AU - Cesare, D. AU - Francesco, A. AU - Muraro, R. PY - 2006 DA - 2006// TI - Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes JO - Arterioscler Thromb Vasc Biol VL - 26 UR - https://doi.org/10.1161/01.ATV.0000249630.02085.12 DO - 10.1161/01.ATV.0000249630.02085.12 ID - Cuccurullo2006 ER - TY - JOUR AU - Mahajan, N. AU - Bahl, A. AU - Dhawan, V. PY - 2010 DA - 2010// TI - C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin JO - Int J Cardiol VL - 142 UR - https://doi.org/10.1016/j.ijcard.2009.01.008 DO - 10.1016/j.ijcard.2009.01.008 ID - Mahajan2010 ER - TY - STD TI - Forbes JM, Thorpe SR, Thallas-Bonke V, Pete J, Thomas MC, Deemer ER, et al. Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy. J Am Soc Nephrol. 2005;16:2363–72. ID - ref21 ER - TY - JOUR AU - Nakamura, K. AU - Yamagishi, S. AU - Nakamura, Y. PY - 2005 DA - 2005// TI - Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension JO - Microvasc Res VL - 70 UR - https://doi.org/10.1016/j.mvr.2005.10.002 DO - 10.1016/j.mvr.2005.10.002 ID - Nakamura2005 ER - TY - JOUR AU - Grossin, N. AU - Boulanger, E. AU - Wautier, M. -. P. AU - Wautier, J. -. L. PY - 2010 DA - 2010// TI - The different isoforms of the receptor for advanced glycation end products are modulated by pharmacological agents JO - Clin Hemorheol Microcirc VL - 45 UR - https://doi.org/10.3233/CH-2010-1292 DO - 10.3233/CH-2010-1292 ID - Grossin2010 ER - TY - JOUR AU - Melin, E. O. AU - Thunander, M. AU - Svensson, R. AU - Landin-Olsson, M. AU - Thulesius, H. O. PY - 2013 DA - 2013// TI - Depression, obesity and smoking were independently associated with inadequate glycemic control in patients with type 1 diabetes JO - Eur J Endocrinol VL - 168 UR - https://doi.org/10.1530/EJE-13-0137 DO - 10.1530/EJE-13-0137 ID - Melin2013 ER - TY - JOUR AU - Melin, E. O. AU - Thulesius, H. O. AU - Hillman, M. AU - Landin-Olsson, M. AU - Thunander, M. PY - 2018 DA - 2018// TI - Abdominal obesity in type 1 diabetes associated with gender, cardiovascular risk factors and complications, and difficulties achieving treatment targets: a cross sectional study at a secondary care diabetes clinic JO - BMC Obes VL - 5 UR - https://doi.org/10.1186/s40608-018-0193-5 DO - 10.1186/s40608-018-0193-5 ID - Melin2018 ER - TY - JOUR AU - Melin, E. O. AU - Thulesius, H. O. AU - Hillman, M. AU - Svensson, R. AU - Landin-Olsson, M. AU - Thunander, M. PY - 2019 DA - 2019// TI - Lower HDL-cholesterol, a known marker of cardiovascular risk, was associated with depression in type 1 diabetes: a cross sectional study JO - Lipids Health Dis VL - 18 UR - https://doi.org/10.1186/s12944-019-1009-4 DO - 10.1186/s12944-019-1009-4 ID - Melin2019 ER - TY - JOUR AU - Melin, E. O. AU - Hillman, M. AU - Thunander, M. AU - Landin-Olsson, M. PY - 2019 DA - 2019// TI - Midnight salivary cortisol secretion and the use of antidepressants were associated with abdominal obesity in women with type 1 diabetes: a cross sectional study JO - Diabetol Metab Syndr VL - 11 UR - https://doi.org/10.1186/s13098-019-0481-3 DO - 10.1186/s13098-019-0481-3 ID - Melin2019 ER - TY - JOUR AU - Melin, E. O. AU - Dereke, J. AU - Thunander, M. AU - Hillman, M. PY - 2018 DA - 2018// TI - Depression in type 1 diabetes was associated with high levels of circulating galectin-3 JO - Endocr Connect VL - 7 UR - https://doi.org/10.1530/EC-18-0108 DO - 10.1530/EC-18-0108 ID - Melin2018 ER - TY - JOUR AU - Melin, E. O. AU - Dereke, J. AU - Hillman, M. PY - 2019 DA - 2019// TI - Female sex, high soluble CD163, and low HDL-cholesterol were associated with high galectin-3 binding protein in type 1 diabetes JO - Biol Sex Differ VL - 10 UR - https://doi.org/10.1186/s13293-019-0268-0 DO - 10.1186/s13293-019-0268-0 ID - Melin2019 ER - TY - STD TI - Melin EO, Dereke J, Thunander M, Hillman M. Soluble CD163 was linked to galectin-3, diabetic retinopathy and antidepressants in type 1 diabetes. Endocr Connect. 2018;7:1343–53. ID - ref30 ER - TY - JOUR AU - Klein, S. AU - Allison, D. B. AU - Heymsfield, S. B. AU - Kelley, D. E. AU - Leibel, R. L. AU - Nonas, C. PY - 2007 DA - 2007// TI - Waist circumference and Cardiometabolic risk: a consensus statement from shaping America’s health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association JO - Obesity. VL - 15 UR - https://doi.org/10.1038/oby.2007.632 DO - 10.1038/oby.2007.632 ID - Klein2007 ER - TY - JOUR AU - Zigmond, A. S. AU - Snaith, R. P. PY - 1983 DA - 1983// TI - The hospital anxiety and depression scale JO - Acta Psychiatr Scand VL - 67 UR - https://doi.org/10.1111/j.1600-0447.1983.tb09716.x DO - 10.1111/j.1600-0447.1983.tb09716.x ID - Zigmond1983 ER - TY - STD TI - The National Board of Health and Welfare. Stockholm, Sweden. Swedish National Guidelines for Diabetes. 2009. https:/www.socialstyrelsen.se. Accessed 13 Mar 2009. UR - http://www.socialstyrelsen.se ID - ref33 ER -